Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 82 citing SHEPP: Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromi.... (0.14 sec) 

Herpes simplex virus resistance to acyclovir and penciclovir after two decades of …

- nih.gov
TH Bacon, MJ Levin, JJ Leary, RT Sarisky, … - Clinical microbiology …, 2003 - Am Soc Microbiol
Acyclovir, penciclovir, and their prodrugs have been widely used during the past two decades
for the treatment of herpesvirus infections. In spite of the distribution of over 2.3 x 10 6 kg of these
nucleoside analogues, the prevalence of acyclovir resistance in herpes simplex virus ...
Cited by 79 - Related articles - BL Direct - All 7 versions

Homopolymer mutational hot spots mediate herpes simplex virus resistance to …

- nih.gov [PDF] 
JJ Sasadeusz, F Tufaro, S Safrin, K Schubert, … - The Journal of …, 1997 - jvi.highwire.org
Page 1. J OURNAL OF V IROLOGY , 0022-538X/97/$04.00 0 May 1997, p. 3872–3878
Vol. 71, No. 5 Copyright 1997, American Society for Microbiology Homopolymer Mutational
Hot Spots Mediate Herpes Simplex Virus Resistance to Acyclovir ...
Cited by 67 - Related articles - BL Direct - All 8 versions

Antiviral therapy: current concepts and practices.

- nih.gov
B Bean - Clinical Microbiology Reviews, 1992 - Am Soc Microbiol
Page 1. CLINICAL MICROBIOLOGY REVIEWS, Apr. 1992, p. 146-182 Vol. 5, No.
2 0893-8512/92/020146-37$02.00/0 Copyright © 1992, American Society for
Microbiology Antiviral Therapy: Current Concepts and Practices ...
Cited by 63 - Related articles - All 6 versions

Treatment of patients with acquired immunodeficiency syndrome and associated …


LD Kaplan, CB Wofsy, PA Volberding - JAMA, 1987 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ...
Cited by 69 - Related articles - All 3 versions

Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex …


B Romanowski, FY Aoki, AY Martel, EA Lavender, JE … - Aids, 2000 - journals.lww.com
Objective: To compare the efficacy and safety of 7 days' treatment with famciclovir 500 mg twice
a day versus acyclovir 400 mg five times a day, for mucocutaneous herpes simplex virus
(HSV) infection in HIV-infected individuals. Design: Randomized, double-blind, parallel- ...
Cited by 63 - Related articles - BL Direct - All 4 versions

Acyclovir prophylaxis for herpes simplex virus infection.

- nih.gov [PDF] 
D Gold, L Corey - Antimicrobial agents and chemotherapy, 1987 - Am Soc Microbiol
Page 1. Vol. 31, No. 3 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 1987, p.
361-367 0066-4804/87/030361-07$02.00/0 Copyright © 1987, American Society for Microbiology
MINIREVIEW Acyclovir Prophylaxis for Herpes Simplex Virus Infection ...
Cited by 57 - Related articles - All 11 versions

Herpes simplex virus infection in the immunocompromised cancer patient

- ascopubs.org [PDF] 
CI Bustamante, JC Wade - Journal of Clinical Oncology, 1991 - jco.ascopubs.org
From the Section of Infectious Diseases and Microbiology, University of Maryland Cancer
Center, Baltimore; and Divi- sions of Infectious Diseases and Oncology, Department of
Medicine, University of Maryland School of Medicine, Balti- more, MD. Submitted January ...
Cited by 48 - Related articles - All 6 versions

Mucositis management practices for hospitalized patients: National survey results


BA Mueller, ET Millheim, EA Farrington, C Brusko, … - Journal of pain and …, 1995 - Elsevier
The optimal management strategies for cancer chemotherapy and radiotherapy-induced mucositis
have not been identified. In 1989, the National Institutes of Health (NIH) published a consensus
statement outlining a standardized approach for the prevention and treatment of oral ...
Cited by 45 - Related articles - All 4 versions

Prevention and treatment of viral infections in stem cell transplant recipients


P Ljungman - British journal of haematology, 2002 - cat.inist.fr
Prevention and treatment of viral infections in stem cell transplant recipients. Per
LJUNGMAN British journal of haematology 118:11, 44-57, Blackwell, 2002. Greffe;
Graft; Injerto; Retroviridae; Retroviridae; Retroviridae; Spumavirinae ...
Cited by 47 - Related articles - BL Direct - All 3 versions

Orofacial herpes simplex virus infections: current concepts in the epidemiology, …


C Scully - Oral Surgery, Oral Medicine, Oral Pathology, 1989 - Elsevier
Herpes simplex virus (HSV) is the causal agent of herpetic stomatitis, recurrent herpes
labialis, and the recurrent intraoral infections seen particularly in the immunocompromised
patient. HSV has also been implicated in some erythema multiforme, cranial ...
Cited by 42 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google